SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.
A clinical trial of an artificial pancreas system showed it was able to outperform current treatments for people with Type 1 diabetes and help maintain blood sugar levels throughout the day as well as ...
Hybrid closed-loop systems are increasingly gaining recognition as a gold-standard option for diabetes management, and medtech makers are jumping at the opportunity to add their own artificial ...
Frans Cromme, Chief Executive Officer of ViCentra, said: "We aim to deliver the best user experience as well as excellent clinical results with our Kaleido insulin pump and our partners. Kaleido with ...
@tandemdiabetes completes 1st hybrid closed loop pilot study w/ integrated #tslimX2 @TypeZeroTech and Dexcom G6 CGM. Post this The hybrid closed loop system predicts high and low blood sugar levels ...
Kaleido is one of the world's smallest and lightest insulin patch pumps, with a low ecological footprint due to its reusable design Paired with the Diabeloop DBLG1 control software and Dexcom G6 CGM ...
Kaleido is one of the world's smallest and lightest insulin patch pumps, with a low ecological footprint due to its reusable design Paired with the Diabeloop DBLG1 control software and Dexcom G6 CGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback